Shampa Das is a Senior Lecturer at the University of Liverpool and a Pharmacokinetics and Pharmacodynamics (PK/PD) consultant.

Following 17 years within the pharmaceutical industry, Shampa has extensive expertise in using PK/PD for developing Clinical Pharmacology and dose strategies to support the clinical development and regulatory approval of new anti-infective drugs. Shampa is a senior leader within the Antimicrobial Pharmacodynamics and Therapeutics group which supports biotechnological and pharmaceutical companies to develop new antimicrobial agents by developing the critical Pharmacokinetics and Pharmacodynamics (PK/PD) package required for dose selection.

As a consultant, Shampa also uses PK/PD to inform critical decisions on adult and paediatric dosing to companies and funders including CARB-X and Wellcome Trust. Shampa is a PK/PD expert in the EUCAST steering committee.